To further analyze the expression level of miR-377 in tumor specimens, we found that miR-377 was significantly up-regulated in acquired gefitinib resistance group (Figure 3F) and was negatively correlative with the expression level of SNHG5 (Figure 3G). The gene discussed is SNHG5; the disease is neoplasm.